Viol Co Ltd
KOSDAQ:335890
Operating Margin
Viol Co Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| KR |
V
|
Viol Co Ltd
KOSDAQ:335890
|
543.9B KRW |
62%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
234.5B USD |
17%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
199.3B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
157B USD |
19%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
149.9B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.7B USD |
19%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
55.1B EUR |
14%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
49.7B USD |
13%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46B USD |
28%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
41.8B USD |
29%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
274B CNY |
34%
|
Viol Co Ltd
Glance View
VIOL Co., Ltd. is engaged in the provision of financial support services. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2019-12-03. The firm's main product is Scarlet, an equipment for elasticity and lifting. In addition, the Company develops and produces medical devices for anti-aging skin care. The firm sells its products in domestic and overseas markets such as China and the United States.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Viol Co Ltd's most recent financial statements, the company has Operating Margin of 62%.
You don't have any saved screeners yet